The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic factors of grade 4 IDH-mutant astrocytoma.
 
Muhammad Asad Maqbool
No Relationships to Disclose
 
Robert B. Jenkins
No Relationships to Disclose
 
Cristiane M. Ida
No Relationships to Disclose
 
Terry C. Burns
Consulting or Advisory Role - Aminex Therapeutics (Inst); Neurametrix (Inst); Predicine (Inst)
Research Funding - Abbvie (Inst); Aminex Therapeutics (Inst); Boehringer Ingelheim (Inst); Codman (Inst); Insightec (Inst); MetVital (Inst); Predicine (Inst); SonaCare Medical (Inst)
Patents, Royalties, Other Intellectual Property - Methods and Materials for Treating Cancer. US Application PCT/US2022/026434 (Inst); Patent 3887685: Drug Delivery and Biomarker Access Devices (Inst)
 
Sani Haider Kizilbash
Consulting or Advisory Role - Sichuan Honghe Biotechnology Co. (Inst); SK Life Sciences (Inst)
Research Funding - Aminex Therapeutics (Inst); Apollomics (Inst); Celgene (Inst); cns pharmaceuticals (Inst); Incyte (Inst); Loxo (Inst); Nerviano Medical Sciences (Inst); Orbus Therapeutics (Inst); Wayshine Biopharma (Inst)